Apyx Medical (NASDAQ:APYX) Trading Down 1.8% - Here's Why

Apyx Medical Corporation (NASDAQ:APYX - Get Free Report)'s share price fell 1.8% during mid-day trading on Monday . The company traded as low as $3.73 and last traded at $3.79. 38,540 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 115,008 shares. The stock had previously closed at $3.86.Analyst Ratings ChangesA number of equities analysts recently commented on APYX shares. Citizens Jmp raised shares of Apyx Medical from a "market perform" rating to an "outperform" rating and set a $8.00 price target on the stock in a research report on Wednesday, November 12th. Weiss Ratings restated a "sell (e+)" rating on shares of Apyx Medical in a research report on Wednesday, October 8th. Roth Capital started coverage on shares of Apyx Medical in a research report on Monday. They issued a "buy" rating and a $6.00 price target for the company. Finally, Wall Street Zen upgraded Apyx Medical to a "hold" rating in a research note on Saturday, November 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Apyx Medical presently has a consensus rating of "Hold" and a consensus price target of $7.00.Get Our Latest Stock Report on Apyx MedicalApyx Medical Trading Down 1.8%The firm's 50-day simple moving average is $3.57 and its 200 day simple moving average is $2.59. The company has a debt-to-equity ratio of 5.69, a current ratio of 4.44 and a quick ratio of 3.61. The firm has a market capitalization of $144.93 million, a price-to-earnings ratio of -10.53 and a beta of 1.48. Apyx Medical (NASDAQ:APYX - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.05. Apyx Medical had a negative return on equity of 151.01% and a negative net margin of 30.35%.The company had revenue of $12.88 million for the quarter, compared to analyst estimates of $12.00 million. Equities analysts expect that Apyx Medical Corporation will post -0.68 earnings per share for the current year. Institutional Investors Weigh In On Apyx MedicalHedge funds have recently made changes to their positions in the stock. Citadel Advisors LLC acquired a new position in Apyx Medical during the 3rd quarter worth approximately $28,000. Fisher Asset Management LLC bought a new stake in shares of Apyx Medical during the second quarter worth $34,000. Caprock Group LLC acquired a new position in shares of Apyx Medical during the third quarter worth $40,000. Osaic Holdings Inc. bought a new position in shares of Apyx Medical in the 2nd quarter valued at $50,000. Finally, Franklin Resources Inc. acquired a new stake in shares of Apyx Medical during the 3rd quarter valued at $59,000. 55.33% of the stock is currently owned by institutional investors and hedge funds. About Apyx Medical (Get Free Report)Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.Featured ArticlesFive stocks we like better than Apyx MedicalTrading Halts ExplainedServiceNow’s $7 Billion Gamble: Panic or Opportunity?10 Best Airline Stocks to BuyDell and HP Are Raising Prices—And Investors Should Take NoteWhat Are Dividends? Buy the Best Dividend StocksWhy DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Apyx Medical Right Now?Before you consider Apyx Medical, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apyx Medical wasn't on the list.While Apyx Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here